{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:15:44Z","timestamp":1784211344567,"version":"3.55.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00393-017-0294-4","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T12:28:04Z","timestamp":1490099284000},"page":"102-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Ambulante Versorgung und Krankheitslast der rheumatoiden Arthritis","Outpatient care and disease burden of rheumatoid arthritis"],"prefix":"10.1007","volume":"77","author":[{"given":"K.","family":"Albrecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Luque Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Callhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Minden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"key":"294_CR1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00393-015-0019-5","volume":"75","author":"K Albrecht","year":"2016","unstructured":"Albrecht K, Callhoff J, Edelmann E, Schett G, Schneider M, Zink A (2016) Klinische Remission bei rheumatoider Arthritis. Daten aus der Fr\u00fcharthritiskohorte CAPEA. Z\u00a0Rheumatol 75:90\u201396","journal-title":"Z Rheumatol"},{"issue":"1","key":"294_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00393-016-0156-5","volume":"76","author":"K Albrecht","year":"2016","unstructured":"Albrecht K, Huscher D, Eidner T, Kleinert S, Sp\u00e4thling-Mestekemper S, Bischoff S, Zink A (2016) Versorgung der rheumatoiden Arthritis 2014. Aktuelle Daten aus der Kerndokumentation. Z\u00a0Rheumatol 76(1):50\u201357. doi:\n                        10.1007\/s00393-016-0156-5","journal-title":"Z Rheumatol"},{"issue":"5","key":"294_CR3","doi-asserted-by":"publisher","first-page":"e00254","DOI":"10.1002\/prp2.254","volume":"4","author":"AM Fassmer","year":"2016","unstructured":"Fassmer AM, Garbe E, Schmedt N (2016) Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany. Pharmacol Res Perspect 4(5):e00254. doi:\n                        10.1002\/prp2.254","journal-title":"Pharmacol Res Perspect"},{"key":"294_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-016-0191-2","author":"S Hense","year":"2016","unstructured":"Hense S, Luque-Ramos A, Callhoff J, Albrecht K, Zink A, Hoffmann F (2016) Pr\u00e4valenz der rheumatoiden Arthritis in Deutschland auf Basis von Kassendaten \u2013 regionale Unterschiede und erste Ergebnisse der PROCLAIR Studie. Z\u00a0Rheumatol. doi:\n                        10.1007\/s00393-016-0191-2","journal-title":"Z Rheumatol"},{"key":"294_CR5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40801-016-0089-y","volume":"3","author":"G Krack","year":"2016","unstructured":"Krack G, Zeidler H, Zeidler J (2016) Claims data analysis of tumor necrosis factor inhibitor treatment dosing among patients with rheumatoid arthritis: a systematic review of methods. Drugs Real World Outcomes 3:265\u2013278","journal-title":"Drugs Real World Outcomes"},{"key":"294_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-016-0174-3","author":"D Pattloch","year":"2016","unstructured":"Pattloch D, Richter A, Manger B, Dockhorn R, Meier L, Tony HP, Zink A, Strangfeld A (2016) Das erste Biologikum bei rheumatoider Arthritis: Einflussfaktoren auf die Therapieentscheidung. Z\u00a0Rheumatol. doi:\n                        10.1007\/s00393-016-0174-3","journal-title":"Z Rheumatol"},{"key":"294_CR7","first-page":"164","volume-title":"Wohnortnahe Betreuung Rheumakranker","author":"HH Raspe","year":"1999","unstructured":"Raspe HH, Hagedorn U, Kohlmann T, Mattussek S (1999) Der Funktionsfragebogen Hannover (FFbH): Ein Instrument zur Funktionsdiagnostik bei polyartikul\u00e4ren Gelenkerkrankungen. In: Siegrist J (Hrsg) Wohnortnahe Betreuung Rheumakranker. Schattauer, Stuttgart, S\u00a0164\u2013182"},{"key":"294_CR8","volume-title":"Interdisziplin\u00e4re Leitlinie. Management der fr\u00fchen rheumatoiden Arthritis","author":"M Schneider","year":"2011","unstructured":"Schneider M, Lelgemann M, Abholz HH et\u00a0al (2011) Interdisziplin\u00e4re Leitlinie. Management der fr\u00fchen rheumatoiden Arthritis, 3.\u00a0Aufl. Springer, Heidelberg","edition":"3"},{"key":"294_CR9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/kep045","volume":"48","author":"G Westhoff","year":"2009","unstructured":"Westhoff G, Schneider M, Raspe H, Zeidler H, Runge C, Volmer T, Zink A (2009) Advance and unmet need of health care for patients with rheumatoid arthritis in the German population \u2013 results from the German Rheumatoid Arthritis Population Survey (GRAPS). Rheumatology (Oxford) 48:650\u2013657","journal-title":"Rheumatology (Oxford)"},{"key":"294_CR10","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s00393-012-1027-3","volume":"71","author":"J Zeidler","year":"2012","unstructured":"Zeidler J, Zeidler H, Graf von der Schulenburg JM (2012) Therapie der rheumatoiden Arthritis mit Methotrexat. Analyse von Versorgungsaspekten anhand von GKV-Routinedaten. Z\u00a0Rheumatol 71:900\u2013907","journal-title":"Z Rheumatol"},{"key":"294_CR11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00393-013-1258-y","volume":"73","author":"A Zink","year":"2014","unstructured":"Zink A (2014) Versorgungsforschung in der Rheumatologie. Aktueller Stand. Z\u00a0Rheumatol 73:115\u2013122","journal-title":"Z Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-017-0294-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0294-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0294-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T13:56:19Z","timestamp":1520517379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-017-0294-4"}},"subtitle":["Eine Analyse von Abrechnungsdaten und einer Versichertenbefragung","Results of a\u00a0linkage of claims data and a\u00a0survey of insured persons"],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1007\/s00393-017-0294-4","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]}}}